What evidence supports lumbar transforaminal epidural steroid injections providing more than 80% relief for radiculopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lumbar Transforaminal Epidural Steroid Injections for Radiculopathy: Evidence for >80% Relief

There is insufficient evidence in the medical literature to support that lumbar transforaminal epidural steroid injections (TFESI) can provide more than 80% pain relief for radiculopathy. The highest documented success rates in the provided studies show approximately 80% immediate response rates, but not exceeding 80% relief.

Evidence from Guidelines and Studies

  • The American Society of Anesthesiologists (ASA) guidelines recommend epidural steroid injections with or without local anesthetics as part of a multimodal treatment regimen for radicular pain or radiculopathy, but do not specify an expected percentage of pain relief 1
  • Epidural steroid injections are supported by the ASA for providing pain relief in selected patients with radicular pain, though the guidelines do not quantify the expected degree of pain relief 1
  • The highest documented success rate found in the provided studies was approximately 80.2% for immediate response in patients with clinically diagnosed lumbar radiculopathy and MRI evidence of nerve root compression 2

Detailed Analysis of Available Evidence

  • In a 2015 study of 232 patients with lumbar radiculopathy, the immediate response rate to TFESI was 80.2%, with 80.3% of single-level radiculopathy patients showing immediate response 2
  • The same study showed that the analgesic effect lasted for more than 12 weeks in only 39.7% of patients, indicating that while initial response may be good, sustained relief at high levels is less common 2
  • A 2020 study reported that 75.29% of patients had more than 50% pain relief at 3 months post-injection, but did not document any patients achieving >80% relief 3

Factors Affecting Treatment Response

  • Symptom chronicity was associated with poor immediate response to TFESI, suggesting that early intervention may yield better results 2
  • The American College of Physicians recommends that patients should have MRI evidence of pathology, such as nerve root compression and moderate to severe disc herniation, to be considered for lumbar epidural steroid injection 4
  • Image guidance (fluoroscopy) is strongly recommended by the ASA for both interlaminar and transforaminal epidural injections to ensure proper needle placement and maximize effectiveness 1

Comparative Effectiveness

  • A 2011 randomized prospective study comparing interlaminar versus transforaminal approaches found that 84% of patients in the transforaminal group had >2cm improvement on VAS pain scale, and 63% had >50% improvement at 24 weeks, but did not report any patients achieving >80% relief 5
  • A 2012 meta-analysis of transforaminal epidural steroid injections showed only modest improvements in pain scores compared to control groups, with no significant differences in disability outcomes 6

Potential Risks and Complications

  • Reported complications of epidural steroid injections include dural puncture, insertion-site infections, cauda equina syndrome, sensorimotor deficits, discitis, epidural granuloma, and retinal complications 1
  • Shared decision making regarding epidural steroid injections should include a specific discussion of potential complications associated with the procedure 1

In conclusion, while lumbar transforaminal epidural steroid injections can provide significant pain relief for radiculopathy, the available evidence does not support relief exceeding 80% in most patients. The highest documented success rates show approximately 80% immediate response, with diminishing effects over time.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical value of transforaminal epidural steroid injection in lumbar radiculopathy.

Hong Kong medical journal = Xianggang yi xue za zhi, 2015

Guideline

Determination of Medical Necessity for Initial Lumbar Epidural Steroid Injection in Patients with Chronic Low Back Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Transforaminal injection of corticosteroids for lumbar radiculopathy: systematic review and meta-analysis.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.